Virtus ETF Advisers LLC Forma Therapeutics Holdings, Inc. Transaction History

Virtus ETF Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.1 - $10.0 $57,293 - $112,340	-11,234 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.34 - $14.69 $5,571 - $9,812	-668 Reduced 5.61%	11,234 $104,000
Q4 2021 Feb 14, 2022	BUY	$13.6 - $24.89 $42,744 - $78,229	3,143 Added 35.88%	11,902 $169,000
Q3 2021 Nov 15, 2021	SELL	$21.22 - $25.7 $9,782 - $11,847	-461 Reduced 5.0%	8,759 $203,000
Q2 2021 Aug 10, 2021	BUY	$22.86 - $30.95 $67,299 - $91,116	2,944 Added 46.91%	9,220 $229,000
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $2,654 - $4,624	108 Added 1.75%	6,276 $176,000
Q4 2020 Feb 12, 2021	BUY	$34.9 - $51.08 $215,263 - $315,061	6,168 New	6,168 $215,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.